Page last updated: 2024-12-06
2,2'-diamino-1,1'-dinaphthyl
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
2,2'-diamino-1,1'-dinaphthyl: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 20571 |
SCHEMBL ID | 455943 |
MeSH ID | M0338065 |
Synonyms (135)
Synonym |
---|
EU-0035118 |
BIDD:GT0420 |
(s)-(-)-1,1'-binaphthyl-2,2'-diamine |
18531-95-8 |
(r)-(+)-1,1'-binaphthyl-2,2'-diamine |
c20h16n2 |
(1,1'-binaphthalene)-2,2'-diamine |
2,2'-diamino-1,1'-dinaphthyl |
1,1'-bi(2-naphthylamine) |
1,1'-bi(2-naphthalenylamine) |
nsc 519704 |
brn 2138401 |
4488-22-6 |
wln: l66j cz b- 2 |
1,1'-bi[2-naphthylamine] |
nsc-519704 |
nsc519704 |
1,1'-bi[2-naphthalenylamine] |
1,1'-binaphthyl-2,2'-diamine, 96% |
(s)-(-)-1,1'-binaphthyl-2,2'-diamine, 99% |
(r)-(+)-1,1'-binaphthyl-2,2'-diamine, 99% |
1-(2-aminonaphthalen-1-yl)naphthalen-2-amine |
AKOS001610329 |
A812948 |
1-(2-azanylnaphthalen-1-yl)naphthalen-2-amine |
1-(2-amino-1-naphthalenyl)-2-naphthalenamine |
A813148 |
18741-85-0 |
(s)-(-)-2,2'-diamino-1,1'-binaphthalene |
1,1-binaphy1-2,2'-diamine |
[1,1'-binaphthalene]-2,2'-diamine |
AKOS015999158 |
tl35mu1249 , |
unii-tl35mu1249 |
4-13-00-00489 (beilstein handbook reference) |
(r)-[1,1'-binaphthalene]-2,2'-diamine |
FT-0637711 |
FT-0637744 |
1,1 inverted exclamation marka-binaphthyl-2,2 inverted exclamation marka-diamine |
racemic-2,2'-diamino-1,1'-binaphthyl |
SCHEMBL455943 |
(s)-(-)-[1,1'-binaphthalene]-2,2'-diamine |
binam |
B3923 |
2,2'-diamino-1,1'-binaphthyl |
1,1'-binaphthyl-2,2'-diamine |
(r)-(+)-[1,1'-binaphthalene]-2,2'-diamine |
(r)-(+)-2,2'-diamino-1,1'-binaphthalene |
AC-11350 |
DS-1947 |
s-(-)-2,2'-diamino-1,1'-binaphthalene |
AC-20456 |
(as)-1,1'-binaphthalene-2,2'-diamine |
(+/-)-1,1'-bi(2-naphthylamine) |
(s)-(-)-1,1'-binaphthalene-2,2'-diamine |
(r)-(+)-1,1'-binaphthalene-2,2'-diamine |
CS-W007978 |
DTXSID70196328 |
SR-01000402740-1 |
sr-01000402740 |
(r)-binam |
(r)-(+)-2,2'-diamino-1,1'-binaphthyl |
(s)-(-)-2,2'-diamino-1,1'-binaphthyl |
mfcd00145204 |
(s)-(-)-2,2/'-diamino-1,1/'-binaphthalene |
(r)-(+)-1,1'-bi(2-naphthylamine) |
J-011888 |
(s)-(-)-1,1'-bi(2-naphthylamine) |
J-012068 |
(s)-(-)-2,2-diamino-1,1-binaphthalene |
(s)-2,2'-diamino-1,1'-binaphthalene |
(r)-2,2'-diamino-1,1'-binaphthalene |
(s)-1,1'-binaphthyl-2,2'-diamine |
79082-81-8 |
CS-0031454 |
BBL103722 |
(r)-2,2 inverted exclamation mark -diamino-1,1 inverted exclamation mark -binaphthalene |
SY011491 |
1,1'-binaphthalene-2,2'-diamine |
STL557532 |
FT-0712593 |
1,1 inverted exclamation mark -binaphthyl-2,2 inverted exclamation mark -diamine |
SY013141 |
SY037270 |
(s)-2,2 inverted exclamation mark -diamino-1,1 inverted exclamation mark -binaphthalene |
n-hexadecanoyl-serinemonosodiumsalt |
(r)-binaphthyldiamine |
(ar)-1,1'-binaphthalene-2,2'-diamine |
(1,1'-binaphthalene)-2,2'-diamine, (1s)- |
(as)-2,2'-diamino-1,1'-binaphthalene |
(s)-binam |
(1,1'-binaphthalene)-2,2'-diamine, (s)-(-)- |
(+)-2,2'-diamino-1,1'-binaphthyl |
(-)-1,1'-binaphthyl-2,2'-diamine |
2,2'-diamino-1,1'-dinaphthyl, (s)- |
unii-7ol97nn4u4 |
(ar)-2,2'-diamino-1,1'-binaphthalene |
(s)-2,2'-diamino-1,1'-binaphthyl |
2,2'-diamino-1,1'-dinaphthyl, (r)- |
7ol97nn4u4 , |
(1,1'-binaphthalene)-2,2'-diamine, (+)- |
(1,1'-binaphthalene)-2,2'-diamine, (1r)- |
xi03tw52ao , |
(r)-1,1'-binaphthalene-2,2'-diamine |
(+)-1,1'-binaphthyl-2,2'-diamine |
unii-xi03tw52ao |
D3208 |
D3207 |
(r)-(+)-binam |
(s)-(-)-binam |
AMY19833 |
(r)-1,1'-binaphthyl-2,2'-diamine |
OL10247 |
OL10248 |
OL10246 |
(s)-(-)- 2,2'-diamino-1,1'-binaphthalene |
Q27290008 |
W16719 |
A851710 |
A851711 |
1-(2-aminonaphthalen-1-yl)naphthalen-2-amine;(r)-[1,1'-binaphthalene]-2,2'-diamine |
(s)-1,1'-binaphthalene-2,2'-diamine |
(r)-2,2'-diamino-1,1'-dinaphthyl |
(1s)-[1,1'-binaphthalene]-2,2'-diamine |
(1r)-[1,1'-binaphthalene]-2,2'-diamine |
(s)-2,2'-diamino-1,1'-dinaphthyl |
(-)-2,2'-diamino-1,1'-binaphthyl |
(+/-)-2,2'-diamino-1,1'-binaphthalene |
(+/-)-1,1'-binaphthyl-2,2'-diamine |
(rs)-1,1'-binaphthalene-2,2'-diamine |
rac-binam |
(+/-)-2,2'-diamino-1,1'-binaphthyl |
2,2'-diamino-1,1'-binaphthalene |
HY-W007978B |
HY-W007978 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (17)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (5.88) | 18.2507 |
2000's | 7 (41.18) | 29.6817 |
2010's | 6 (35.29) | 24.3611 |
2020's | 3 (17.65) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.02
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.02) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 1 (5.88%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 16 (94.12%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |